VTVT
vTv Therapeutics·NASDAQ
--
--(--)
--
--(--)
VTVT fundamentals
vTv Therapeutics (VTVT) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.92 (YoY -13.58%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.92
-13.58%
Report date
Aug 12, 2025
EPS
Actual | -4.4 | -3.2 | -0.8 | 0.8 | -3.2 | -0.4 | -0.8 | -3.2 | -4 | -1.6 | -2 | -2.4 | -2.4 | -2.8 | -3.2 | -1.67 | -1.17 | -0.81 | -0.88 | -0.55 | -0.77 | -0.92 | |||||||
Forecast | -4 | -3.8 | -4.2 | -2.2 | -2.4 | -2.8 | -2.6 | -2.5333 | -2.8 | -3.6 | -1.7333 | -2.5333 | -3.8 | -2.8 | -3.2 | -2.8 | -3.2 | -3.2 | -3.6 | -0.87 | -0.815 | -0.825 | |||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -10.00% | +15.79% | +80.95% | +136.36% | -33.33% | +85.71% | +69.23% | -26.32% | -42.86% | +55.56% | -15.39% | +5.26% | +36.84% | 0.00% | 0.00% | +40.36% | +63.44% | +74.69% | +75.56% | +36.78% | +5.52% | -11.52% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 8.00K | 0 | 7.00K | 6.40M | 987.00K | 9.00K | 3.00M | 9.00K | 2.00M | 9.00K | 0 | 9.00K | -- | -- | -- | -- | 1.00M | 0 | 0 | 17.00K | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 3.30M | 800.00K | 1.00M | 1.30M | 500.00K | 0 | 0 | 250.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +93.91% | +23.38% | -99.10% | +130.77% | -98.20% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from vTv Therapeutics's earnings call?What is vTv Therapeutics's gross profit margin?What is the market's earnings forecast for vTv Therapeutics next quarter?What factors drove the changes in vTv Therapeutics's revenue and profit?What does vTv Therapeutics do and what are its main business segments?What guidance did vTv Therapeutics's management provide for the next earnings period?Did vTv Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from vTv Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
